Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Anatomic Stage II Breast Cancer AJCC v8 × tucatinib × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 10 Colorectal Neoplasms 4 Neoplasms 3 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Rectal Neoplasms 1 Pathologic Complete Response 1 Neoplasm Metastasis 1 Meningeal Neoplasms 1 Hemangiosarcoma 1 HER2-positive Metastatic Breast Cancer 1 HER2-positive Breast Cancer 1 Gallbladder Neoplasms 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Brain Neoplasms 1 Adenocarcinoma Of Esophagus 1 Adenocarcinoma 1

Interventions

Taxes 2 Paclitaxel 2 trastuzumab biosimilar HLX02 1 pertuzumab 1 durvalumab 1 Trastuzumab 1 Surgical Procedures, Operative 1 Specimen Handling 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiotherapy 1 Radiation 1 PF-05280014 1 Ontruzant 1 Ogivri 1 Mastectomy, Segmental 1 Mastectomy 1 Magnetic Resonance Spectroscopy 1 Immunoglobulin G 1 High-Energy Shock Waves 1 Genetic Testing 1 Fluorodeoxyglucose F18 1 Drug Therapy 1 Doxorubicin 1 Docetaxel 1 Disulfides 1 Cyclophosphamide 1 Albumin-Bound Paclitaxel 1 Ado-Trastuzumab Emtansine 1 2C4 antibody 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡